DexCom, Inc.
DXCMFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
4,033
Cost of Revenue
1,595
Gross Profit
2,438
Gross Margin
60.5%
Operating Income
600
Operating Margin
14.9%
Net Income
576
Net Margin
14.3%
EPS (Basic)
$1.46
EPS (Diluted)
$1.42
EBITDA
946
EBITDA Margin
23.4%
2023
12/31/2023
Revenue
3,622
Cost of Revenue
1,333
Gross Profit
2,289
Gross Margin
63.2%
Operating Income
598
Operating Margin
16.5%
Net Income
542
Net Margin
14.9%
EPS (Basic)
$1.44
EPS (Diluted)
$1.30
EBITDA
917
EBITDA Margin
25.3%
2022
12/31/2022
Revenue
2,910
Cost of Revenue
1,027
Gross Profit
1,883
Gross Margin
64.7%
Operating Income
391
Operating Margin
13.4%
Net Income
341
Net Margin
11.7%
EPS (Basic)
$0.88
EPS (Diluted)
$0.80
EBITDA
565
EBITDA Margin
19.4%
2021
12/31/2021
Revenue
2,449
Cost of Revenue
768
Gross Profit
1,681
Gross Margin
68.6%
Operating Income
266
Operating Margin
10.9%
Net Income
217
Net Margin
8.9%
EPS (Basic)
$0.56
EPS (Diluted)
$0.51
EBITDA
378
EBITDA Margin
15.4%
2020
12/31/2020
Revenue
1,927
Cost of Revenue
647
Gross Profit
1,280
Gross Margin
66.4%
Operating Income
300
Operating Margin
15.5%
Net Income
494
Net Margin
25.6%
EPS (Basic)
$1.31
EPS (Diluted)
$1.27
EBITDA
377
EBITDA Margin
19.6%